<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00209872</url>
  </required_header>
  <id_info>
    <org_study_id>OMA-AH01</org_study_id>
    <secondary_id>eudraCT # 2005-003595-38</secondary_id>
    <nct_id>NCT00209872</nct_id>
  </id_info>
  <brief_title>Optimal Multimodal Analgesia in Abdominal Hysterectomy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hvidovre University Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the current standard of care (SOC) treatment for
      abdominal hysterectomy with a group receiving SOC minus epidural analgesia plus additional
      perioperative analgesics in terms of postoperative abilities, postoperative nausea and
      vomiting (PONV), pain and discharge time from the PACU (post-anaesthesia care unit).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim of the study: to compare postoperative complaints (PONV, pain, etc) and PACU discharge
      time between two groups, for patients admitted for planned abdominal hysterectomy with or
      without BSO:

        -  A: standard of care (SOC) receiving paracetamol, celecoxib, epidural analgesia,
           dexamethasone, ondansetron and droperidol, and general anaesthesia with propofol,
           remifentanil and cisatracurium

        -  B: SOC with sham epidural analgesia, preoperative gabapentin, intraoperative lidocaine,
           s-ketamine and sufentanil
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2005</start_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative abilities over time</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Discharge time from PACU according to fixed criteria</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Consumption of analgesics and antiemetics in the PACU</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Degree of nursing requirements at the PACU</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General tolerability of the regimes</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Threshold for sensory perception and pain using the Pain Matcher device, pre- and postoperatively</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Planned Abdominal Hysterectomy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>S-ketamine</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Epidural analgesia</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Planned abdominal hysterectomy with or without BSO

          -  Age above 18 years

          -  Written informed consent

          -  American Society of Anesthesiologists (ASA) class I-III

        Exclusion Criteria:

          -  Planned vaginal or laparoscopic hysterectomy

          -  Hysterectomy as part of other surgery

          -  Allergy to part of the treatment regimen

          -  Previous reactions to opioids (nausea, cognition)

          -  Previous inability to place correct epidural catheter

          -  Severe state anxiety according to the OCAP or STAI

          -  ASA class IV

          -  Dependency on alcohol, opioids or central stimulants

          -  Chronic pain condition

          -  Hemorrhagic diathesis

          -  Participation in another study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth Jensen, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Anaesthesia, Acute Pain Service, Hvidovre Hospital, Copenhagen, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claus Lund, Dr. Med. Sci.</last_name>
    <role>Study Chair</role>
    <affiliation>Dept. of Anaesthesia, Hvidovre Hospital, Copenhagen, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kenneth Jensen, M.D.</last_name>
    <phone>+45 36 32 62 90</phone>
    <email>kenneth.jensen@hh.hosp.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dept. of Anaesthesia, Hvidovre Hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Hvidovre</state>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kenneth Jensen, M.D.</last_name>
      <phone>+45 36 32 62 90</phone>
      <email>kenneth.jensen@hh.hosp.dk</email>
    </contact>
    <investigator>
      <last_name>Kenneth Jensen, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.postoppain.org</url>
    <description>URL looking into anaesthesia and surgery for abdominal hysterectomy</description>
  </link>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2005</study_first_submitted>
  <study_first_submitted_qc>September 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2005</study_first_posted>
  <last_update_submitted>November 6, 2007</last_update_submitted>
  <last_update_submitted_qc>November 6, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 7, 2007</last_update_posted>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Gabapentin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

